Lizhuang Shu
YOU?
Author Swipe
View article: Bmi1 facilitates the progression of cholangiocarcinoma by inhibiting Foxn2 expression dependent on a histone H2A ubiquitination manner
Bmi1 facilitates the progression of cholangiocarcinoma by inhibiting Foxn2 expression dependent on a histone H2A ubiquitination manner Open
Cholangiocarcinoma (CCA), an exceptionally aggressive malignancy originating from the epithelium of the bile duct, poses a formidable challenge in cancer research and clinical management. Currently, attention is focused on exploring the on…
View article: The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment
The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment Open
Cholangiocarcinoma (CCA) is a highly aggressive malignant tumor that originates from the biliary system. With restricted treatment options at hand, the challenging aspect of early CCA diagnosis leads to a bleak prognosis. Besides the intri…
View article: Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma
Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma Open
Cholangiocarcinoma (CCA) is a highly malignant tumor of the hepatobiliary system that has failed to respond to many traditional therapies to a certain extent, including surgery, chemotherapy and radiotherapy. In recent years, the new thera…
View article: Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers
Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers Open
Biliary tract cancers (BTCs), including cholangiocarcinoma and gallbladder carcinoma, originate from the biliary epithelium and have a poor prognosis. Surgery is the only choice for cure in the early stage of disease. However, most patient…